The valve is narrowed.
Severity, symptoms, heart response, anatomy, and progression shape whether monitoring, TAVR, or surgery belongs in the discussion—and how urgent that discussion may be.

Virtual aortic valve second opinion
For U.S. patients and families advised to have aortic valve surgery: a cardiac surgeon and cardiologist review your imaging, proposed plan, and relevant options online.
No referral or call is required to purchase. Start online from home.
FIRST, NAME THE VALVE PROBLEM
The diagnosis starts the conversation. Severity, symptoms, anatomy, heart response, and the rest of the heart determine which questions belong.
Severity, symptoms, heart response, anatomy, and progression shape whether monitoring, TAVR, or surgery belongs in the discussion—and how urgent that discussion may be.
Cause, ventricular response, aortic anatomy, and repairability create a different fork. Surgical replacement or selected reconstruction may be relevant; catheter treatment applies to a narrower group. The actual anatomy, cause of the leak, symptoms, and surgical risk require review by the treating multidisciplinary valve team.
Symptoms, valve area, velocity, gradients, ventricular response, and serial change help explain why intervention is—or is not—being discussed now.
Valve morphology, annular dimensions, calcium pattern, coronary height, aortic dimensions, and vascular access can change what is technically reasonable.
Age is context—not a verdict. A single cutoff cannot decide the right path for an individual; expected longevity, durability, reintervention, pacemaker risk, paravalvular leak, and future coronary access belong in the same conversation.
Coronary disease, an enlarged aorta, another valve, or a rhythm procedure may favor a combined operation or a different sequence.
Clinical boundary: severe aortic stenosis can become life-threatening, especially when symptoms or heart-function changes are present. Continue following your treating team’s instructions while seeking clarification.
OPTIONS, IN CONTEXT
The review identifies only the paths that fit the documented diagnosis and anatomy. It does not choose treatment, promise candidacy, or replace the treating valve team.
Transcatheter aortic valve replacement replaces the valve through a catheter; it does not repair the native valve. It may offer a shorter initial recovery for appropriately selected patients, while anatomy, access, pacemaker risk, paravalvular leak, durability, and future coronary access still matter.
Surgical aortic valve replacement permits a mechanical or tissue prosthesis and can also address bypass disease, the aorta, another valve, or selected rhythm procedures during the same operation.
For selected regurgitation or aortic-root anatomy, repair or valve-sparing reconstruction may be discussed. The report may also identify questions about continued surveillance, missing workup, or whether the timing should be reassessed with the treating team.
The lifetime question: what fits this heart now, and what could today’s valve choice mean for the next procedure?
WHITEGLOVE Insights™
The report connects the proposed treatment to the complete record, makes uncertainty visible, and prepares your next conversation with the clinicians responsible for your care.
Severity, symptoms, serial testing, heart response, treating team’s plan, and the findings driving the discussion—clearly tied to the source record.
Benefits, burdens, technical considerations, and unanswered questions for TAVR, SAVR, reconstruction, monitoring, or another path only when it fits this case.
Durability, reintervention, coronary access, prosthesis choice, and the current STS ACSD operative-risk estimate when applicable—with verified inputs, calculation date, missing data, and model limits visible. Other models appear only when documented in the source record.
Questions about timing, procedure-specific experience, complex-aortic capability, geography, practical considerations, and reliable public outcomes when requested and available.
FOUR CLEAR SERVICE LEVELS
Every package includes both independent reviews and one co-signed report. Higher levels add live physician time and support.
Compare every package detailThe complete two-physician written review, without a live consultation.
The same written review, plus one reviewing physician live.
The same written review, plus both reviewers together live.
Heart Team access plus support through the day of surgery.
WHAT SHAPES THE REVIEW
A missing study does not automatically mean care was inadequate. It means the limits of the review should be visible and turned into useful questions.
Valve severity, ventricular response, other valves, and serial change—not only one number from one study.
Annulus, calcium pattern, coronary height, aortic dimensions, and vascular access when a catheter procedure is being considered.
Whether coronary disease is present and whether bypass or another strategy changes the choice or sequence.
Whether an enlarged aorta, mitral disease, or another structural problem belongs in the same decision.
The clinical and laboratory variables needed for a defensible estimate, with missing data and model limitations shown.
Mobility, frailty, pulmonary and kidney status, recovery, anticoagulation, future procedures, travel, caregiving, and tolerance for uncertainty.
INDEPENDENT DUAL REVIEW
Both physicians review independently, confer, and co-sign your report. Neither replaces the clinicians who know and treat you.

Cardiovascular and thoracic surgeon
Reviews SAVR, prosthesis strategy, operative access, the aorta, combined procedures, and risk.
Interventional cardiologist
Reviews severity, progression, TAVR anatomy, coronary context, imaging, and surveillance.The goal is not manufactured disagreement. It is a decision whose reasoning you can see.
Meet the physiciansHOW IT WORKS
No referral or travel is required. You can purchase first, then upload records securely.
Purchase directly or request a complimentary call if you want help comparing service levels.
Upload what you have. With your authorization, our records team can help identify and request what is missing.
A cardiac surgeon and cardiologist examine the same complete record from different clinical perspectives, then confer.
The report is delivered within 24 hours only after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window.
EVIDENCE, WITH LIMITS VISIBLE
Risk estimates describe modeled outcomes for patients with similar inputs. They do not predict an individual result and do not replace clinical judgment.
A second opinion can be useful when aortic valve intervention is being proposed and you want to understand the timing, whether TAVR or surgical replacement fits the documented anatomy, what another heart or aortic condition adds to the decision, or how today’s choice may affect future procedures. It should not delay urgent or time-sensitive care directed by your treating team.
Neither option is better for every patient. TAVR may offer a shorter initial recovery for appropriately selected patients. Surgical replacement may be more suitable for certain anatomy, lifetime-management goals, or cases that also need bypass, aortic repair, another valve procedure, or rhythm surgery. The review explains how those considerations apply to the available record without choosing treatment for you.
Age is context—not a verdict. A single cutoff cannot decide the right path for an individual. Expected longevity, anatomy, frailty, valve durability, potential reintervention, future coronary access, other cardiac disease, and personal priorities all belong in the broader lifetime-management discussion with the treating team.
It can. Bicuspid morphology, the pattern of calcification, annular and aortic dimensions, coronary anatomy, and associated enlargement of the aorta may affect the technical feasibility and tradeoffs of catheter-based and surgical approaches. The decision requires the actual imaging and clinical context.
When surgical valve replacement is relevant, the report can organize the tradeoffs between mechanical and tissue prostheses. A mechanical valve requires lifelong vitamin K antagonist anticoagulation, usually warfarin. A tissue valve usually does not require lifelong anticoagulation solely because of the valve, but it can deteriorate over time; another condition may still require anticoagulation. The final choice belongs with you and your treating physicians.
The exact record depends on the decision. It commonly includes echocardiogram images and reports, CT imaging when TAVR is being evaluated, catheterization or coronary assessment, clinical notes, laboratory results, medication history, and the proposed treatment plan. With your authorization, the records team can help identify, request, and organize what is needed.
A cardiac surgeon and cardiologist independently review the same complete record, confer, and co-sign one patient-facing WHITEGLOVE Insights™ report. Both perspectives are included in every package.
The report is delivered within 24 hours only after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window.
The four one-time package prices are $495 for Insights™, $995 for Consult, $1,495 for Heart Team, and $2,495 for Concierge. Every package includes two independent physician reviews and one co-signed written report. Higher levels add live physician access and support. WHITEGLOVEMD is a direct-pay service and does not submit insurance claims.
No. WHITEGLOVEMD provides independent educational decision support and medical-record review. It does not diagnose, prescribe, perform procedures, provide emergency care, or replace the physicians responsible for your treatment.
THE DECISION STAYS YOURS
Choose a package and begin online, or request a complimentary call if you want help deciding.